AGTR1 and atherosclerosis: The mechanisms by which metformin inhibits atherosclerosis can be categorized into three main types: activation of autophagy, disruption of angiotensin-II-type-1 receptor (AT1R), and upregulation of antioxidant enzyme superoxide dismutase 1 (SOD1).